WHO database ‘shows safety signal’ for semaglutide and suicidal ideation: study
The study of a WHO database found no similar signal for liraglutide.
Researchers have called for an urgent assessment of a possible link between semaglutide and suicidality based on a study of a WHO adverse event database.
Their study, published in JAMA Network Open on Wednesday, found a higher reporting rate for suicidal ideation with semaglutide compared with other medications in the database (odds ratio 1.45).
